Latest Posts
About This Stock
More About This Stock
Read
Read
E Merck: This Pharmaceutical Giant Has Significant Upside Potential

Article By:
SureDividend
Friday, January 8, 2021 9:42 PM EST
Merck is a highly profitable dividend stock with a long runway of growth up ahead. With a reasonable valuation and a solid 3% yield, the stock is a buy.
Dogs Of The Dow 2021

Article By:
Dividend Power
Wednesday, January 6, 2021 7:19 PM EST
The Dogs of the Dow is an investing strategy that is by now fairly well-known to many small investors. The 10 stocks from the Dow 30 that have the highest yield on the last day of the year comprise the Dogs for the Dow for the following year.
OncoSec Raising Its Profile In Fight Against Cancer
I appreciate a promising investment that also helps people. Bullish on $ONCS and $MRK.
OncoSec Raising Its Profile In Fight Against Cancer
Thanks for this info, Terry Chrisomalis. Is there any sort of official partnership or cooperation between #OncoSecMedical and #Merck to use ImmunoPulse IL-12 technology in conjunction with #Keytruda? $ONCS $MRK
OncoSec Raising Its Profile In Fight Against Cancer
Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY